Optimizing Hidradenitis Suppurativa Care: Biologics, Combos, Surgery
Expert guidance from HCPlive focuses on optimizing HS biologics, combination therapy and surgical timing in hidradenitis suppurativa management across disease stages.
Topic
Inflammatory Skin Disease
Topic
Inflammatory Skin Disease
HS Management Spotlighted: Comorbidities, Expectations, Wound Care
HCPLive's latest report on hidradenitis suppurativa centers expectation-setting, comorbidity screening, and structured wound care…
Jennifer Hsiao, MD, on Hidradenitis Suppurativa Treatment Selection
Jennifer Hsiao, MD, shares practical tips on HS treatment selection and comorbidity screening in a new Dermatology Times conversa…
Sanofi Commits Up to $8B to Broaden Regeneron Antibody Alliance
Sanofi has committed up to $8 billion to expand its antibody-development partnership with Regeneron. The renewed agreement center…
First World Chronic Hand Eczema Day Set for October 5
October 5 marks the inaugural World Chronic Hand Eczema Day, a new global observance raising awareness of an often-overlooked ski…
EADV 2026 Presenters Link Climate Shifts to Skin Disease Burden
EADV 2026 presenters link climate change to shifting skin disease patterns worldwide, with implications for incidence surveillanc…
Skin-Bone Marrow Axis Identified as New Therapeutic Target in Psoriasis
Newly identified skin-bone marrow communication pathway reframes psoriasis as systemic immune crosstalk, pointing toward progenit…
Simone Biles Fronts Arcutis' 'Skin to Believe' Campaign
Arcutis Biotherapeutics has launched 'Skin to Believe,' a consumer awareness campaign fronted by Olympic gymnast Simone Biles, Dr…